JW

Jalaja Wariyar Subramonia

Director Director DIN 02009525
DIN 02009525 First appointment Feb 2008 Primary industry Construction
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Jalaja Wariyar Subramonia

Data last updated:

Jalaja Wariyar Subramonia was a Director at Buddha Smriti Udhyaan Development Compan Y Limited (2008) and Nominee Director at Indian Medicines Pharmaceutical Corporation Limited (2009–2010). The companies operate in Construction and Healthcare.

DIN 02009525
Primary Designation Director
Industry Construction
First Appointment 18 Feb 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20082008Dissolved (Liquidated)
Nominee Director13 Aug 20091978₹164 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Buddha Smriti Udhyaan Development Compan Y Limited
Indian Medicines Pharmaceutical Corporation Limited
Premium access

Shareholding and investment profile for Jalaja Wariyar Subramonia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jalaja Wariyar Subramonia

Jalaja Wariyar Subramonia was first appointed on 18 Feb 2008 as Director at Buddha Smriti Udhyaan Development Compan Y Limited. The most recent appointment on record is 13 Aug 2009 at Indian Medicines Pharmaceutical Corporation Limited.

Jalaja Wariyar Subramonia held 2 earlier board appointments: Buddha Smriti Udhyaan Development Compan Y Limited (Director, 18 Feb 2008 to 20 Nov 2008); Indian Medicines Pharmaceutical Corporation Limited (Nominee Director, 13 Aug 2009 to 01 Nov 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available